全文获取类型
收费全文 | 884篇 |
免费 | 87篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 42篇 |
妇产科学 | 9篇 |
基础医学 | 155篇 |
口腔科学 | 13篇 |
临床医学 | 116篇 |
内科学 | 241篇 |
皮肤病学 | 26篇 |
神经病学 | 20篇 |
特种医学 | 160篇 |
外科学 | 39篇 |
综合类 | 18篇 |
预防医学 | 52篇 |
眼科学 | 6篇 |
药学 | 46篇 |
2篇 | |
肿瘤学 | 44篇 |
出版年
2021年 | 6篇 |
2020年 | 7篇 |
2019年 | 9篇 |
2018年 | 10篇 |
2017年 | 26篇 |
2016年 | 4篇 |
2015年 | 13篇 |
2014年 | 14篇 |
2013年 | 21篇 |
2012年 | 20篇 |
2011年 | 19篇 |
2010年 | 21篇 |
2009年 | 25篇 |
2008年 | 16篇 |
2007年 | 41篇 |
2006年 | 37篇 |
2005年 | 18篇 |
2004年 | 25篇 |
2003年 | 22篇 |
2002年 | 28篇 |
2001年 | 28篇 |
2000年 | 29篇 |
1999年 | 26篇 |
1998年 | 36篇 |
1997年 | 40篇 |
1996年 | 40篇 |
1995年 | 29篇 |
1994年 | 30篇 |
1993年 | 26篇 |
1992年 | 13篇 |
1991年 | 17篇 |
1990年 | 21篇 |
1989年 | 43篇 |
1988年 | 29篇 |
1987年 | 37篇 |
1986年 | 18篇 |
1985年 | 31篇 |
1984年 | 14篇 |
1983年 | 11篇 |
1982年 | 8篇 |
1981年 | 10篇 |
1980年 | 14篇 |
1979年 | 6篇 |
1978年 | 4篇 |
1977年 | 14篇 |
1976年 | 7篇 |
1972年 | 4篇 |
1971年 | 6篇 |
1968年 | 3篇 |
1967年 | 4篇 |
排序方式: 共有990条查询结果,搜索用时 515 毫秒
1.
Davies S. P.; Webb W. J. S.; Patou G.; Murray W. K.; Denning D. W. 《Nephrology, dialysis, transplantation》1987,2(6):568-572
The second documented case of renal aspergilloma due to Aspergillusflavus is presented. The merits of the medical therapy thatfailed are discussed. Pathological examination showed a nidusof aspergillus around suture material persisting from a pyelolithotomyoperation 2 years before in India. We argue that this was thereason for the failure of the medical therapy. This is the firstcase of its kind reported. 相似文献
2.
V Allen PhD DW Ryan MB FRCA A Murray PhD FIPSM 《International journal of clinical practice》1994,48(3):125-129
SUMMARY Four specialised air mattresses had interface pressure measured under six body sites prone to pressure sores in 10 subjects, supine and sitting. The mattresses were the Clinirest (SSI) and FirstStep (KCI) continuous airflow mattress overlays, and Airwave (Pegasus) and Nimbus (Huntleigh) alternating pressure air mattresses. On the mattress overlays, average supine interface pressures were 2.33 kPa (scapula), 4.15 kPa (elbow), 1.94 kPa (sacrum) and 2.79 kPa (buttock), although they were higher at the occiput (7.97 kPa) and heel (11.7 kPa). The alternating pressure air mattresses had an average minimum interface pressure close to zero for three sites, rising to 4.28 kPa under the heel. Average maximum interface pressures were 8.61 kPa (occiput), 5.21 kPa (scapula), 4.90 (elbow), 4.85 kPa (sacrum), 4.61 kPa (buttock) and 13.2 kPa (heel). No accepted scientific method exists for comparing the two types of mattress. Our data suggest a clinical benefit at the occiput and heel (supine) in using an alternating pressure air mattress and a benefit in using a continuous airflow mattress overlay at other sites. 相似文献
3.
4.
Eleven radiologists appointed by the major radiological societies participated for the past 5 years in the development of the Health Policy Agenda for the American People. The Agenda is an action plan to address a wide variety of serious problems in medicine. The first phase involved establishment of 159 principles, broad value statements that were the foundation of the project. Phase 2 involved the development of policy proposals on 38 urgent issues for action in medical science; education; health resources; delivery mechanisms; evaluation, assessment, and control; and payment for services. These proposals are summarized in this report. The activities and recommendations of representatives for the field of radiology are described. The Agenda has been released, and an implementation phase has begun. It will likely be of great importance to the practice of radiology over the next decade. Important issues can be addressed by acting with the coalitions that are being formed from among the more than 150 participating organizations. 相似文献
5.
6.
7.
8.
The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. 总被引:66,自引:15,他引:51 下载免费PDF全文
9.
H.?SambatakouEmail author M.?Guiver D.?Denning 《European journal of clinical microbiology & infectious diseases》2003,22(11):681-685
A 25-year-old male with chronic granulomatous disease developed severe bilateral pulmonary aspergillosis confirmed by a positive result of polymerase chain reaction for Aspergillus species from sputum and positive serological tests for Aspergillus. He was successfully treated with voriconazole. The diagnostic difficulties and the new therapeutic options in the era of new antifungal agents are discussed. 相似文献
10.
Abrams DI Bebchuk JD Denning ET Davey RT Fox L Lane HC Sampson J Verheggen R Zeh D Markowitz NP;Terry Beirn Community Programs for Clinical Research on AIDS 《Journal of acquired immune deficiency syndromes (1999)》2002,29(3):221-231
The effect of intermittent courses of recombinant interleukin-2 (rIL-2) on HIV-1 load in patients receiving combination antiretroviral therapy remains uncertain. CPCRA 059 was an open-label, randomized, multicenter trial in which 511 patients with HIV-1 infection and CD4+ cell counts of > or = 300/mm3 who were receiving antiretroviral therapy were assigned to receive no rIL-2 (255 patients [controls]) or subcutaneous rIL-2 in dosages of 4.5 MIU (130) or 7.5 MIU (126) twice daily for 5-day courses every 8 weeks to maintain CD4+ cell counts that were twice the baseline value or > or = 1,000/mm3. The primary objective of this study was to compare the effects of the two doses of rIL-2 and no rIL-2 on viral load and CD4+ cell counts over 12 months. There was no difference in the following viral load measurements between the rIL-2 treatment groups and the control treatment group: percentage of patients with viral loads of <50 copies/mL at 12 months (p =.55), time to viral load of > or = 50 copies/mL for patients who had baseline viral loads of <50 copies/mL (p =.35), and change in viral load from baseline for patients who had viral loads of > or = 50 copies/mL at baseline (p =.63). At each follow-up visit, the change in CD4+ cell count from baseline was significantly greater in the rIL-2 treatment groups than in the control treatment group, with a mean difference of 251/mm3 at month 12 (95% confidence interval, 207-295; p <.0001). No unanticipated adverse experiences were seen in this trial, to our knowledge the largest randomized evaluation of rIL-2 treatment conducted to date. 相似文献